Impact of Cilostazol Pharmacokinetics on the Development of Cardiovascular Side Effects in Patients with Cerebral Infarction

MLA

Toshio Maeda, et al. “Impact of Cilostazol Pharmacokinetics on the Development of Cardiovascular Side Effects in Patients with Cerebral Infarction.” Biological and Pharmaceutical Bulletin, vol. 44, Nov. 2021, pp. 1767–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....53132e66f52086c3daf26db9a9df6aad&authtype=sso&custid=ns315887.

APA

Toshio Maeda, Keishi Yamagata, Yoshinori Asahara, Yoshiyuki Kagawa, Tasuku Yokoyama, Yumiko Urano, Yuta Kaneshiro, Shigeru Yamauchi, & Keiji Murata. (2021). Impact of Cilostazol Pharmacokinetics on the Development of Cardiovascular Side Effects in Patients with Cerebral Infarction. Biological and Pharmaceutical Bulletin, 44, 1767–1774.

Chicago

Toshio Maeda, Keishi Yamagata, Yoshinori Asahara, Yoshiyuki Kagawa, Tasuku Yokoyama, Yumiko Urano, Yuta Kaneshiro, Shigeru Yamauchi, and Keiji Murata. 2021. “Impact of Cilostazol Pharmacokinetics on the Development of Cardiovascular Side Effects in Patients with Cerebral Infarction.” Biological and Pharmaceutical Bulletin 44 (November): 1767–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....53132e66f52086c3daf26db9a9df6aad&authtype=sso&custid=ns315887.